PSG5 Antikörper (N-Term)
Kurzübersicht für PSG5 Antikörper (N-Term) (ABIN630155)
Target
Alle PSG5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- PSG5 antibody was raised against the N terminal of PSG5
-
Aufreinigung
- Purified
-
Immunogen
- PSG5 antibody was raised using the N terminal of PSG5 corresponding to a region with amino acids QLMDLYHYITSYVVDGQINIYGPAYTGRETVYSNASLLIQNVTREDAGSY
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PSG5 Blocking Peptide, (ABIN5615614), is also available for use as a blocking control in assays to test for specificity of this PSG5 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PSG5 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PSG5 (Pregnancy Specific beta-1-Glycoprotein 5 (PSG5))
-
Andere Bezeichnung
- PSG5
-
Hintergrund
- The pregnancy-specific beta 1 glycoprotein (PSG) is a group of heterogeneous proteins produced in large amounts by the human syncytiotrophoblast. They belong to the carcinoembryonic antigen (CEA) family. The function of PSG5 remains unknown.
-
Molekulargewicht
- 37 kDa (MW of target protein)
Target
-